| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Aeder | 570 | 46% |
| Examiner Darpolor | 7 | 0% |
| Examiner Goddard | 467 | 49% |
| Examiner Jean-Louis (SPE) | 454 | 63% |
| Examiner Lee | 6 | 0% |
| Examiner Lu | 157 | 50% |
| Examiner Moseley | 403 | 66% |
| Examiner Priest | 0 | 0% |
| Examiner Stonebraker | 19 | 16% |
| Examiner Sullivan | 92 | 39% |
| Examiner Xiao | 413 | 66% |
| Art Unit 1642 | 2588 | 55% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 435 | Chemistry: molecular biology and microbiology |
| 514 | Drug, bio-affecting and body treating compositions |
| 530 | Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 436 | Chemistry: analytical and immunological testing |
| 536 | Organic compounds -- part of the class 532-570 series |
| 702 | Data processing: measuring, calibrating, or testing |
| 562 | Organic compounds -- part of the class 532-570 series |
| 600 | Surgery |
Art Unit 1642's grant rate is lower than that of Group 1640 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1642, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.